These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 39281418)

  • 41. Sodium-glucose co-transporter protein 2 (SGLT2) inhibitors for people with chronic kidney disease and diabetes.
    Natale P; Tunnicliffe DJ; Toyama T; Palmer SC; Saglimbene VM; Ruospo M; Gargano L; Stallone G; Gesualdo L; Strippoli GF
    Cochrane Database Syst Rev; 2024 May; 5(5):CD015588. PubMed ID: 38770818
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Continuous erythropoiesis receptor activator (CERA) for the anaemia of chronic kidney disease.
    Saglimbene VM; Palmer SC; Ruospo M; Natale P; Craig JC; Strippoli GF
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD009904. PubMed ID: 28782299
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Tunnicliffe DJ; Palmer SC; Cashmore BA; Saglimbene VM; Krishnasamy R; Lambert K; Johnson DW; Craig JC; Strippoli GF
    Cochrane Database Syst Rev; 2023 Nov; 11(11):CD007784. PubMed ID: 38018702
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety and Efficacy of GLP-1 Receptor Agonists in Type 2 Diabetes Mellitus with Advanced and End-Stage Kidney Disease: A Systematic Review and Meta-Analysis.
    Krisanapan P; Sanpawithayakul K; Pattharanitima P; Thongprayoon C; Miao J; Mao MA; Suppadungsuk S; Tangpanithandee S; Craici IM; Cheungpasitporn W
    Diseases; 2024 Jan; 12(1):. PubMed ID: 38248365
    [No Abstract]   [Full Text] [Related]  

  • 45. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.
    Cooper TE; Teng C; Tunnicliffe DJ; Cashmore BA; Strippoli GF
    Cochrane Database Syst Rev; 2023 Jul; 7(7):CD007751. PubMed ID: 37466151
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effectiveness of educational or behavioral interventions on adherence to phosphate control in adults receiving hemodialysis: a systematic review.
    Milazi M; Bonner A; Douglas C
    JBI Database System Rev Implement Rep; 2017 Apr; 15(4):971-1010. PubMed ID: 28398983
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effectiveness of Multifaceted Care Approach on Adverse Clinical Outcomes in Nondiabetic CKD: A Systematic Review and Meta-analysis.
    Bello AK; Qarni B; Samimi A; Okel J; Chatterley T; Okpechi IG; Vandermeer B; Braam B
    Kidney Int Rep; 2017 Jul; 2(4):617-625. PubMed ID: 29142980
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence of polypharmacy and associated adverse health outcomes in adult patients with chronic kidney disease: protocol for a systematic review and meta-analysis.
    Okpechi IG; Tinwala MM; Muneer S; Zaidi D; Ye F; Hamonic LN; Khan M; Sultana N; Brimble S; Grill A; Klarenbach S; Lindeman C; Molnar A; Nitsch D; Ronksley P; Shojai S; Soos B; Tangri N; Thompson S; Tuot D; Drummond N; Mangin D; Bello AK
    Syst Rev; 2021 Jul; 10(1):198. PubMed ID: 34218816
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Correlation between soluble klotho and chronic kidney disease-mineral and bone disorder in chronic kidney disease: a meta-analysis.
    Fan Z; Wei X; Zhu X; Yang K; Tian L; Du Y; Yang L
    Sci Rep; 2024 Feb; 14(1):4477. PubMed ID: 38396063
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dietary Approaches to Stop Hypertension and risk of chronic kidney disease: A systematic review and meta-analysis of observational studies.
    Mozaffari H; Ajabshir S; Alizadeh S
    Clin Nutr; 2020 Jul; 39(7):2035-2044. PubMed ID: 31669002
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum Calcification Propensity and Clinical Events in CKD.
    Bundy JD; Cai X; Mehta RC; Scialla JJ; de Boer IH; Hsu CY; Go AS; Dobre MA; Chen J; Rao PS; Leonard MB; Lash JP; Block GA; Townsend RR; Feldman HI; Smith ER; Pasch A; Isakova T;
    Clin J Am Soc Nephrol; 2019 Nov; 14(11):1562-1571. PubMed ID: 31658949
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association between serum Klotho concentration and all-cause and cardiovascular mortality among American individuals with hypertension.
    Yan Y; Chen J
    Front Cardiovasc Med; 2022; 9():1013747. PubMed ID: 36457804
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of renin-angiotensin-aldosterone system blockade in adults with diabetes mellitus and advanced chronic kidney disease not on dialysis: a systematic review and meta-analysis.
    Nistor I; De Sutter J; Drechsler C; Goldsmith D; Soler MJ; Tomson C; Wiecek A; Donciu MD; Bolignano D; Van Biesen W; Covic A
    Nephrol Dial Transplant; 2018 Jan; 33(1):12-22. PubMed ID: 29106631
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Protective Role of Klotho in CKD-Associated Cardiovascular Disease.
    Bi X; Yang K; Zhang B; Zhao J
    Kidney Dis (Basel); 2020 Nov; 6(6):395-406. PubMed ID: 33313060
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mortality and mode of dialysis: meta-analysis and systematic review.
    Chander S; Luhana S; Sadarat F; Parkash O; Rahaman Z; Wang HY; Kiran F; Lohana AC; Sapna F; Kumari R
    BMC Nephrol; 2024 Jan; 25(1):1. PubMed ID: 38172835
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum magnesium, mortality, and cardiovascular disease in chronic kidney disease and end-stage renal disease patients: a systematic review and meta-analysis.
    Xiong J; He T; Wang M; Nie L; Zhang Y; Wang Y; Huang Y; Feng B; Zhang J; Zhao J
    J Nephrol; 2019 Oct; 32(5):791-802. PubMed ID: 30888644
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The association between platelet-lymphocyte ratio and the risk of all-cause mortality in chronic kidney disease: a systematic review and meta-analysis.
    Gan W; Guan Q; Hu X; Zeng X; Shao D; Xu L; Xiao W; Mao H; Chen W
    Int Urol Nephrol; 2022 Nov; 54(11):2959-2967. PubMed ID: 35581444
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sleep apnoea syndrome prevalence in chronic kidney disease and end-stage kidney disease patients: a systematic review and meta-analysis.
    Pisano A; Zoccali C; Bolignano D; D'Arrigo G; Mallamaci F
    Clin Kidney J; 2024 Jan; 17(1):sfad179. PubMed ID: 38186876
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.